a b s t r a c t L-Dopa is the major symptomatic therapy for Parkinson's disease, which commonly occurs in elderly patients. However, the effects of chronic use on mood and cognition in old subjects remain elusive. In order to compare the effects of a chronic pulsatile L-Dopa treatment on emotional and cognitive functions in young (3 months) and old (18 months) intact rats, an L-Dopa/carbidopa treatment was administered every 12 h over 4 weeks. Rats were assessed for behavioural despair (repeated forced swimming test, RFST), anhedonia (sucrose preference test, SPT) and spatial learning (Morris water maze, MWM) in the late phase of treatment (T). Neuronal expression of Fos in the hippocampus at the early and late phases of T, as well as after MWM was studied. The density and ratio of dopamine D5r, D3r and D2r receptors were also evaluated in the hippocampus using immunohistochemistry and confocal microscopy. Young rats showed similar patterns during behavioural tests, whereas aged treated rats showed increased immobility counts in RFST, diminished sucrose liquid intake in SPT, and spatial learning impairment during MWM. Fos expression was significantly blunted in the aged treated group after MWM. The density of D5r, D3r and D2r was increased in both aged groups. The treatment reduced the ratio of D5r/D3r and D5r/D2r in both groups. Moreover, aged treated subjects had significant lower values of D5r/D3r and higher values of D5r/D2r when compared with young treated subjects. These results indicate that chronic L-Dopa treatment in itself could trigger emotional and cognitive dysfunctions in elderly subjects through dopamine receptor dysregulation.
Introduction
L-3,4-dihydroxyphenylalanine (L-Dopa or levodopa) is the direct precursor of dopamine (DA) (Elsworth and Roth, 1997; Nutt, 1987) and has been suggested to have direct effects on DA receptors (Goshima, 1993) . It is widely used in the therapy of Parkinson's disease (PD) (National Collaborating Centre for Chronic Conditions (UK), 2006) and has also been used, although to a minor extent, to treat some neurological and psychiatric disorders such as Alzheimer's disease (Martorana et al., 2008) and schizophrenia (Jaskiw and Popli, 2004) . It has been implicated as a potential substance for drug abuse (Limotai et al., 2012; Spigset and von Scheele, 1997; Witjas et al., 2012) .
Whether the use of L-Dopa can induce DA system dysregulation in treated subjects is controversial (Macdonald and Monchi, 2011) . Although there are several studies showing that L-Dopa is toxic in vitro (Corona-Morales et al., 2003 Mytilineou et al., 2003) , there is little convincing evidence suggesting that L-Dopa, at its therapeutic dose, exerts dysregulatory effects on the in vivo dopaminergic system (Evans and Lees, 2004; Olanow et al., 2009 ). The plasmatic half-life of the widely used L-Dopa/carbidopa is about 2 1/ 2 h (Chana et al., 2003) . Hence, a twice-daily L-Dopa/carbidopa therapeutic scheme produces pulsatile intracerebral L-Dopa concentration (Schapira, 2003) . Furthermore, the erratic absorption of L-Dopa makes the pulsatility unpredictable (Nutt, 1987) . Most neurotransmitter-receptor systems compensate for over-or understimulation with a reduction in responsiveness or desensitization, or an enhanced responsiveness or supersensitivity, respectively. In general, results from in vivo and in vitro studies of DA receptor regulation fit within this scheme (Creese et al., 1981; Sibley and Neve, 1997) . However, the functional limits of this resilience mechanism can be surpassed by external or internal factors, such as drug dose, pulsatility, ageing, etc. It is commonly accepted that DA D1r-class of receptors (D1r and D5r) activates the Ga s/olf family of G proteins to stimulate cAMP production by adenylyl cyclase (AC). These are found exclusively postsynaptically on dopaminereceptive cells. D5r is highly expressed in the hippocampus (Ciliax et al., 2000; Jay, 2003; Marsdan, 2006; Meador-Woodruff et al., 1992; Sunahara et al., 1991) . The DA D2r-class of receptors (D2r, D3r, and D4r) couples to the Ga i/o family of G proteins and thus induces inhibition of AC. In contrast to the D1-class of DA receptors, D2r and D3r DA receptors are expressed both postsynaptically and presynaptically (Beaulieu and Gainetdinov, 2011; Sokoloff et al., 2006) and are highly expressed in the hippocampal region (Khan et al., 1998) . D2r and D3r have been reported to be modified prominently during the L-Dopa treatment (Joyce, 2001; Joyce et al., 2004) .
DA critically contributes to cellular consolidation of hippocampal-dependent memories by modifying synaptic plasticity in hippocampal neurons (Frey et al., 1991; O'Carroll et al., 2006) , and is particularly sensitive to ageing (Amenta et al., 2001) . Hippocampal dopaminergic innervation arises mainly from the midbrain, and is part of the mesolimbic dopaminergic pathway (Scatton et al., 1980; Swanson, 1982) . It has been shown that activation of the ventral tegmental area (VTA) leads to DA release in the hippocampus (Jay, 2003) . Recent studies (Bolam and Pissadaki, 2012; Pissadaki and Bolam, 2013) have suggested that the unique cellular architecture of both the nigro-striatal and mesolimbic dopaminergic pathways makes them differentially susceptible in PD. Substantia nigra pars compacta (SNc) DA neurons possess large, complex axonal arborizations, which put them under a tight energy budget that makes them particularly susceptible to factors that contribute to cell death. However, this seems not to be the case for mesolimbic VTA DA neurons (Bolam and Pissadaki, 2012) . Hence, the effects of a systemically increased L-Dopa availability can have differential impacts on the nigro-striatal and mesolimbic dopaminergic pathways, and the latter modulates emotionality and cognitive function (Nieoullon and Coquerel, 2003) .
In view of the above findings, it becomes important to ask what the impact(s) of the systemic increase of L-Dopa availability are on the mesolimbic dopaminergic pathway. One strategy to dissect them is to expose young and old rats to chronic and pulsatile L-Dopa treatment and subsequently examine them for possible mood and cognition impairments with well-validated tests. Hence, we hypothesize that a global increase in the dopaminergic tone, due to L-Dopa administration, can impair cognitive and emotional functions in old subjects possibly through modification of dopaminergic receptors. We have evaluated this hypothesis using a hippocampus-dependent spatial learning task and the consequences of L-Dopa treatment on the activation of the hippocampus by assessing the expression of the immediate early gene Fos as well as the dopaminergic receptor densities and their ratios.
Material and methods

Animals and treatment
Sixty-eight male Wistar rats from the local animal facility were used in this study. All animal procedures were approved by the local bioethical and research committees in accordance with the principles exposed in the National Institute of Health Guide for the Care and Use of Laboratory Animals (NIH Publications No. 80-23) revised 1996. Rats were housed two per cage, maintained on an inverted 12-h light schedule in a room with controlled temperature between 20 C and 24 C with adequate ventilation, and given access to standard rat chow and water ad libitum.
Rats were separated into two groups. The "Young" group comprised of 34 threemonth old male rats (250 g AE 15 g b. w.): 17 "Control Young" and 17 L-Dopa-treated "L-Dopa Young". The "old" group comprised of 34 eighteen-month old male rats (600 g AE 25 g, b. w.): 17 "Control Old" and 17 L-Dopa-treated " L-Dopa Old". The experimental young and old groups were treated with oral L-Dopa/carbidopa dose 25mg/2.5 mg per kg, (Sinemet Ò 250/25 mg, L-Dopa/carbidopa, Merck & Co., Inc.) twice daily (period T ¼ 12 h). The tablet was grinded and the corresponding amounts were mixed with soft cheese pellets (approximately 1 g of wet weight per pellet). Experimental subjects were previously habituated with the soft-cheese pellets for about 3 days until the rats ate the pellets readily. The experimenter watched over the drug/cheese intake process until each subject ate the corresponding pellet in its entirety. This administration was continued for four weeks in a twice-daily schedule (at the beginning of the light-and dark-periods). The control groups received the soft-cheese pellets only, in the same schedule.
The reason for which we used this unconventional drug administration method is because we aimed to examine mood and cognition functions in young and old rats under a chronic and pulsatile treatment of L-dopa e our experimental-treatment variable. It was important to avoid any treatment-related stressful events, such as oral gavage or intraperitoneal injection. Based on this reasoning, we established this low-stress drug/soft-cheese co-administration method. Both cheese (in pellets of 1 g) and drug (corresponding dosage per subject) were weighed using an analytical balance before being mixed. After a 3-day training period in which we gave only cheese pellets directly to the rats, the pellets were completely eaten as soon as they were introduced to the cage, on small weighing boats (generally in less than 30 s). In this way, we were able to administer the precise dosage of drug without introducing significant stress, an important condition for the behavioural tests.
Behavioural assessments
All behavioural assessments were carried out at the late phase of the T, i.e. after more than 10 h of the last L-Dopa dose.
Repeated forced swimming test (RFST)
After 4 weeks of L-Dopa treatment, young and old rats (n ¼ 7) were assessed for depressionelike behaviour using a modified version of forced swimming test in which experimental subjects were repeatedly exposed to the swimming stressor. Briefly, the modified Porsolt forced swim test paradigm used (Porsolt et al., 1977a; Zhang et al., 2008) (McLaughlin et al., 2003) was a 2-day procedure in which rats swam without the opportunity to escape. In all trials, rats were placed in a Plexiglas cylinder (45 cm tall Â 30 cm in diameter) containing 30 cm of water, kept at 24 C. After the trial, rats were removed, dried with towels, and returned to their home cages for at least 10 min before further testing. On day 1, animals were placed in water to swim for a single trial of 15 min. The time spent immobile in the last 5 min of the trial was recorded. On day 2, animals were again placed in water to swim but in a series of four trials, each 6 min long. Trials were separated by a 12e15 min return to a home cage. Swimming behaviour was recorded with a video camera, and immobility during minutes 2e6 was analysed off-line according to criteria described elsewhere (Detke et al., 1995; Zhang et al., 2008) . Briefly, the observer gave a score of either "swimming" or "immobile" every 5 s. A rat was judged to be immobile when it remained floating, making only minimum necessary movements to keep its head over the surface without horizontal displacement. Percentages of immobility counts out of total counts (60) were calculated.
Sucrose preference test (SPT)
After the forced swimming test, the same rats were singly housed and presented to a sucrose solution drop dispenser (3% sucrose in H 2 O) and a plain water drop dispenser side by side during 24 h in order to let the rats habituate to the sweet liquid. Concluding this period, the dispensers were removed and the rats underwent water deprivation for 6 h. Subsequently, the drop dispensers with a previously quantified liquid volume were placed in the same locations for the next 24 h allowing the rats to drink ad libitum and undisturbed. Completing this period, the liquid consumption was measured and the sucrose liquid drinking volume, as a percentage of the total liquid consumption, was calculated. This test has been used for anhedonia assessment and was first described by Willner et al. (Willner et al., 1987) .
Morris water maze (MWM)
After 4 weeks of L-Dopa treatment, spatial learning was evaluated with a separate set of rats (n ¼ 10) during the beginning of the dark period, using a modified version of MWM described elsewhere (Hernandez et al., 2012; Nissen et al., 2012) . Rats were exposed to the swimming pool without the platform for 2 min one day before, aiming to habituate them to this experimental procedure and reduce the stress caused by novelty. The test consisted of eight consecutive trials with 5 min rest intervals and was video-recorded. Off-line blind analysis was made.
In order to ensure that this L-Dopa treatment scheme did not produce locomotor alterations, the swimming speed in the first trial was measured as follows: the swimming paths were manually traced using an acetate projection sheet placed on a monitor and traced with a marker while playing the experimental recording. Swimming velocity was measured only when rats were swimming and floating movements were eliminated. The tracings were then digitalized and the swimming distance per minute was measured with the "NeuroJ" plugin for ImageJ (Meijering et al., 2004) . Path lengths were divided by latencies and velocity was obtained (expressed as cm/s).
Immunohistochemistry (IHC)
For perfusion-fixation, rats were deeply anesthetized with an overdose of pentobarbital (63 mg/kg) and perfused for 15 min transcardially with 0.9% saline followed by cold ice fixative containing paraformaldehyde 4% in 0.1M sodium phosphate buffer (PB, pH 7.4) plus 15% v/v of saturated picric acid. After perfusion, the brains were removed from the skull, thoroughly rinsed with PB and brain vibratome sections of 70 mm were collected.
IHC against Fos
To evaluate the neuronal activity the protein product of the proto-oncogene fos was used (Kovacs, 1998) . Fos is best detected in the interval between 60 and 120 min after a neuron is activated (Kovacs, 1998) . Hence, we chose the following time-points after the last L-Dopa administration: a) early phase of T: 3 h after last L-Dopa administration (Basal 3 h, n ¼ 4); b) late phase of T: 12 h after last L-Dopa administration (Basal 12 h, n ¼ 4); c) sixty minutes after MWM test (MWM, n ¼ 4). It is worth mentioning that L-Dopa plasmatic concentration peaks around 2 h after administration and drops to a negligible level at 10e11 h after administration (Chana et al., 2003; Khor and Hsu, 2007) . Hence, the late phase of T represented a virtual abstinence phase.
For IHC, every third section spanning from Bregma e 3.6 mm to Bregma e 4.3 mm, according to the Paxinos and Watson brain atlas (Paxinos G, 1998) , were blocked with 20% normal goat serum (NGS) in Tris-buffered (0.05M, pH 7.4) saline (0.9%) plus 0.3% of Triton X-100 (TBST) for 1 h at room temperature (RT) and then immunoreacted overnight with rabbit anti-Fos primary antibody (SC52, 1:1000, Santa Cruz Biotechnology, Santa Cruz, CA) in TBST þ1% NGS at 4 C with gentle shaking. Afterwards, sections were rinsed three times for 10 min with TBST and then incubated for 2 h at RT with biotinylated goat anti-rabbit secondary antibody (1:200; Vector Labs, Burlingame, CA). Finally, sections were incubated in avidin-biotinperoxidase complex (Elite ABC kit, Vector Labs) for 1 h at RT. Peroxidase was detected using diaminobenzidine 0.05% as chromogen. Sections were rinsed and permanently mounted with Permount mounting medium (Electron Microscopy Sciences, Hatfield, PA). Fos immunoreactive nuclei per 540 mm of length of cell body layers were counted using a Nikon Eclipse 50i microscope and a drawing tube.
IHC against dopamine receptors
Four rats per group were perfused as previously described (Section 2.3). One sagittal section per subject, containing dorsal and ventral hippocampus (lateral 3.9 mm according to the Paxinos and Watson brain atlas (Paxinos G, 1998) , was selected for IHC against the DA receptors. It is worth noting that the fixation, cutting and IHC procedures were strictly controlled to be uniform for all rats and all the freely floating brain sections were labelled with different cuts and underwent the IHC reaction inside the same vial. Sections were blocked with 20% normal donkey serum (NDS) in Tris-buffered (0.05M, pH 7.4) saline (0.9%) plus 0.3% of Triton X-100 (TBST) for 1 h at RT and then immunoreacted overnight with the following primary antibodies: guinea pig against D2r (1:1000, Frontier Institute, Af500); rabbit against D3r (1:1000, Chemicon, AB1786p); mouse against D5r (1:1000, Chemicon, MAB5292). After the incubation, the slices were washed three times with TBST and incubated for 2 h with the following secondary antibodies: CY5 donkey against guinea pig (AP193S, Millipore); Alexa 594 donkey against rabbit (A-21207, Molecular probes); Alexa 488 donkey against mouse (A-21202, Molecular probes). Sections were rinsed and mounted with Vectashield mounting medium. Analysis of signal intensity was done in photographs taken at 20Â with a confocal Leica microscope at 1.5 mm of thickness. For image acquisition and initial observation, Leica LASAF software was used, while the Fiji version of ImageJ (Schindelin et al., 2012) , was used to calculate the signal intensity, in 50 mm Â 50 mm areas inside the cell body layer for each reading of the corresponding receptor at CA1, CA2, CA3 and dentate gyrus regions.
Data analyses
Quantitative results were expressed as mean AE SEM. Multiple pair-comparisons were performed using Bonferroni post hoc test after ordinary one-way, two-way or three way analysis of variance (ANOVA), specified in the "result section" for each experiment. For RFST, second day analysis, and MWM, repeated measures analysis of variance (RM-ANOVA) followed by Bonferroni post hoc test were used, where 'trials' was the within-subject factor and 'treatment' was the between-subject factor. Post hoc differences were considered statistically significant at a value p < 0.05 (*p < 0.05, **p < 0.01, ***p < 0.001).
In order to better understand each population's dynamic behaviour during the MWM spatial learning task, probability of escape was analysed. The escape latency of the individuals was treated as a different data point and then its frequency was collected using bins of five seconds for each of the four groups (Age e Treatment). The frequency count was used to construct the cumulative frequency distribution. The normalization of the cumulative frequency to the total of data points in each population defines the cumulative probability function of escape latency (CPFEL). Then a cumulative Weibull distribution function was fitted to the CPFEL using Matlab R2012a (MathWorks Inc., Natick, MA). The cumulative Weibull distribution functionf ðxÞ ¼ 1 À e Àðt=lÞ k , where k is the shape parameter and l is the scale parameter, was chosen and is commonly used in survival analysis. The cumulative distribution function obtained in this way provided additional information about the groups analysed because it better fits the naturally random aspects of rat behaviour, and because it is a direct measure of the probability of escape. It also allows us to determine the halftime of escape and the spread of the escape latency distribution. In order to test for statistical differences between the models, we compare the resulting parameters from the non-linear fit with an F statistic. As it will be shown below, this analytical model has the advantage that it naturally follows the logic of the experiment and it is able to reveal new characteristics in the interpretation of the MWM spatial learning behaviour.
Results
Behavioural despair measured with RFST was only observed in the old-treated group
The repeated forced swimming test (RFST) allows for the assessment of depression-like behaviour, on both acute (first day of the test) and repeated exposure (second day of the test) and helps to rule out the possibility of motor impairments. Seven rats per experimental group were exposed to the RFST. For the first day data, one-way ANOVA was applied. The analysis showed that the percentage of immobility differed significantly between age groups, (p < 0.01, F (3,27) ¼ 6.816), but not between treatments within the same age group.
For the second day data, repeated measure-two-way ANOVA was used. Analysis showed that in both age groups, the effect of the factor trial was significant (p < 0.001, F (3,36) ¼ 35.31 for young and F (3,36) ¼ 40.66 for old subjects). Treatment had no significant effect on young rats (p ¼ 0.427, F (1,36) ¼ 0.675), however a significant effect was shown on old rats (p < 0.01, F (1,36) ¼ 11.09). No interaction between treatment and trial was found in either group. Young control and L-Dopa-treated rats showed similar immobility patterns along the entire course of the test (Fig. 1A) . In contrast, old animals treated with L-Dopa showed a significant increase in immobility in trials II (p < 0.01), III (p < 0.05) and IV (p < 0.05) of the second day of the test when compared to the corresponding control group (Fig. 1B) .
Sucrose intake test revealed anhedonia in L-Dopa treated old rats
Anhedonia, a behavioural expression of hyposensitivity to reward, is interpreted as a symptom of depression and is commonly tested in rats as a decreased consumption of a sweet palatable solution. After 4 weeks of pulsatile L-Dopa administration, anhedonia was assessed by means of the sucrose (3% sucrose solution) intake test in a 24hr period. One-way ANOVA showed that the percentage of sucrose intake in old rats treated with L-Dopa was significantly reduced compared with all other groups (p < 0.001, F (3,27) ¼ 42.94) (Fig. 2) .
Chronic pulsatile L-Dopa treatment effectively impaired spatial learning in old rats
The effect of the long-term pulsatile administration of L-Dopa on spatial learning was tested using the MWM test. Data was analysed using a mixed model analysis of variance (ANOVA) of the MWM latency time of escape, with factors age (young, old), treatment (cheese pellets with or without L-Dopa) and trial with repeated measures (I, II, III, IV, V, VI, VII, VIII). The non-sphericity of the data was significant, as reported from the Mauchly test. To correct for the nonesphericity, we used the Huynh -Feldt correction. Using this correction, three factor interaction was significant, F (4,193) ¼ 2.815, p ¼ 0.023. Then, in order to search for the interactions we restricted our analysis to a mixed model ANOVA leaving the age factor fixed, again assigning the factor trial as the repeated measures.
In the young rat group, the interaction between trial and treatment was not significant, F (7, 154) ¼ 0.821, p ¼ 0.571. The main effect trial was significant, (F (7,154) ¼ 47.245, p < 0.001). These results indicate that the spatial learning process increases with repetition ( Fig. 3A) , but there was no effect of the treatment in the young group. In the case of the old group, both the interaction and the main effect were significant: F (7,154) ¼ 5.101, p < 0.001 and F (7,154) ¼ 34.6, p < 0.001. Then again, the learning process was different along between the trials but a significant difference due to the treatment is shown (Fig. 3B) . The Bonferroni post hoc test showed that both the young and old control rats found the platform in significant less time compared to the L-Dopa treated aged rats in trials III, V and VII. Fig. 3C combined the panels A and B. In this panel, a subtle difference between the control groups (young vs. old) can be seen (see insert of panel D, where we analyse the curve "shape" parameter kappa (one can easily observe the similitude inside and the difference between the age groups). Fig. 3D shows the cumulative probability of the escape latency (CPFEL) for the different groups. The symbols represent the experimental data and the segmented lines the corresponding non e linear fit. A clear difference in the CPFEL was observed for the L-Dopa old group in which half of the population reached the platform with times lower than 22.5 s. The insert in Fig. 3D shows the estimators for the shape (k) and the scale (l) parameters (open symbols) with their 95% CI (error bar). The estimators are showed in segmented lines in the inset. It can also be seen that the halftime of escape is greater only for the old treated group (Fig. 3D, right insert) , while the halftime of escape for the three other groups is statistically the same. Nonetheless, the data distribution for the control old group, reflected by the curve shape estimator (k), was different compared to the young groups (Fig. 3D, left insert) . With this representation, the individual variation became part of the population behaviour and the differences between the groups could be clearly visualized.
The L-Dopa treatment did not produce locomotor alterations as revealed by swimming speed analysis
The swimming speed measured for the first trial of the MWM test is showed in Table 1 . No differences were found between control and L-Dopa treated groups, whereas significant differences were detected between age groups (Table 1) .
3.5. "Spontaneous" Fos expression in hippocampus at "basal 12 h" in the treated groups and dampened Fos induction by MWM in the old treated group
The expression of Fos was evaluated in the hippocampus (CA1, CA3 and DG) after 4 weeks of pulsatile L-Dopa administration at three different time-points: 3 h and 12 h after the last L-Dopa administration, and 1 h after MWM using immunohistochemical method (see Fig. 4, panels A Minimum Fos expression levels were found in all groups at 3 h after the last administration of L-Dopa, (Fig. 4 , panel A and blue bars of panels D, E, F). However, at the 12 h point, young and old treated animals showed a significant increase (p < 0.001) in the neuronal activation in the CA3 and DG hippocampal subfields (Fig. 4, panel B and green bars of panels D, E, F). The spatial learning test induced a further significant increase of Fos expression in all groups when compared with the basal 12 h condition (p < 0.001) (Fig. 4 , panel C and red bars of histograms D, E and F). However, the relative Fos elevation induced by the MWM was blunted in the old treated group, especially in the DG (Fig. 4, panel F, C .O vs L.O., shade segments).
3.6. The density of D5r, D3r and D2r was increased in the old groups and the treatment differentially modified the ratios D5r/D3r and D5r/D2r, between the age groups Using IHC and confocal microscopy, D5r, D2r and D3r optical density measurements were performed in the CA1, CA2, CA3 and DG hippocampal subfields, the results of a two-way ANOVA analysis (treatment þ age pooled as group), showed significant effects of: group (p < 0.001; CA1: F (3,138) ¼ 777.9; CA2: F (3,108) ¼ 469. By performing confocal microscopic observation, we found that D5r, D3r and D2r were mainly localized at the somata and the proximal segments of the main dendrites (Fig. 5 , panels A 0 and B 0 and Fig. 6 ). The distribution of immunoreactivity for the three studied receptors was not homogeneous through the hippocampus subfields but displayed a CA2/3, CA1 and DG gradient. A significantly increased density of the D5r, D3r and D2r was found in the aged control group as compared with the young control rats (Fig 5, A panels compared to B panels, and histogram of 5C). L-Dopa treatment had no effect on D5r expression in young subjects, except in DG where a reduction was observed. In contrast, the treatment enhanced the D5r expression in aged rats in all hippocampal regions evaluated. Conversely, the treatment enhanced globally the D3r and D2r expression in both young and aged rats, except in CA3 and DG of young subjects where no significant differences were detected (Fig. 6 , panels As and Bs, C, D, E, F), We next examined the modification of D5r/D3r and D5r/D2r ratios as consequences of ageing and L-Dopa treatment. Because binding of D5r and D2r/D3r produces opposing influences on adenylyl cyclase signalling cascades, as previously mentioned in the "Introduction", and the experimental data mentioned above indicated that the three DA receptors studied here were mostly coexpressed in the same cellular compartments, the ratio of D5r/D3r and D5r/D2r become important factors for dopaminergic neurotransmission homeostasis (Neve, 2005; Thompson et al., 2010) . The assessment of these indicators after chronic L-Dopa treatment Fig. 5 . Hippocampal dopamine receptor expression in control rats. A and A 0 and As: low and high magnification of immunofluorescence photomicrographs of ventral hippocampus of old rat. D5r (red), D3r (green) and D2r (blue); B and B 0 and Bs: the same region of a young rat processed with the same immunohistochemical conditions. Scale bars: A, B: 500 mm; As and Bs: 50 mm; A 0 and B 0 : 10 mm. G. C and D: Histograms showing the immunofluorescence optical density differences of D5r, D3r, D2r in dorsal (dHi) and ventral (vHi) hippocampal cell body layers between old and young control subjects (C) and the ratio between D5r/D3r, D5r/D2r in the above regions. ***p < 0.001, **p < 0.01. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.) provides a functional measurement of the dopaminergic system regulation in different treatment/age groups.
Ageing per se produced reduction in the ratio of D5r/D3r in CA1 and CA2 regions, and D5r/D2r in CA 1e3 in control rats (old rats vs. young rats) (Fig 5D) . Treatment further globally reduced these ratios (Fig. 6, C 0 eF 0 ) . Moreover, aged treated subjects had significantly lower values of D5r/D3r and higher values of D5r/D2r when compared with young treated subjects in most of the regions evaluated (Fig. 6, C 0 , D 0 , E 0 , F 0 ) .
Discussion
The results from this series of experiments provide the first evidence that chronic treatment with a therapeutic dose of L-Dopa could exert an age-dependent effect regarding the genesis of depression-like behaviour, anhedonia and cognitive dysfunction. A blunted Fos induction after performing a spatial learning task in the old treated group, compared both with its age-control group and treatment-reference from young rats, indicates that the age-related decline of neuroplasticity can make this group particularly susceptible to a centrally acting drug, such as L-Dopa. We also observed a significant reduction in the ratios between D5r/D3r and D5r/D2r in both treated groups compared with their respective controls, which is consistent with previously reported data (Beaulieu and Gainetdinov, 2011; Creese et al., 1981; Sibley and Houslay, 1994) . Surprisingly, however, we found differential reductions in D5r/D3r and D5r/D2r by the treatment between the age groups: significant lower values for D5r/D3r and higher values for D5r/D2r were observed when comparing old vs. young treated subjects. A functional interpretation of this finding is currently lacking. Nevertheless, our data suggests that ageing plays a crucial role on DA receptor dysregulation in L-Dopa treated subjects.
The effects of a long-term pulsatile L-Dopa treatment on hippocampus dependent spatial learning in aged subjects
Previous reports have found that after long-term administration of L-Dopa, normal monkeys developed L-Dopa-induced dyskinesia (Pearce et al., 2001; Togasaki et al., 2001 ). However, young rats treated with one daily dose of L-Dopa for five days showed an improvement in learning and memory tests (Reinholz et al., 2009 ). It is worth noting that these authors evaluated learning 30 min after the last L-Dopa administration, but studies on other timepoints during the pulsatile drug administration cycle were missing. Moreover, there is an absence of well-controlled studies on the effect of L-Dopa on cognition and emotionality in old subjects in spite of it being a therapeutic agent commonly used in elderly people with PD. DA modulatory effect for cognitive functions is a complex phenomenon and subtly controlled by the temporal variation of the levels of ligand/receptors and the presence of growth factors (for instance, brain derived neurotrophic factor regulate D3r expression in a development-dependent manner (Guillin et al., 2001) .
There are few studies assessing the effects of chronic L-Dopa treatment in an intact dopaminergic system ( (Hagenah et al., 1999) for instance). Some studies in humans have shown cognition improvement in subjects given L-Dopa after stroke, brain trauma or hypoxic-ischemic episodes (Knecht et al., 2004) . However, young subjects were always used in those reports (Mytilineou et al., 2003) (Reinholz et al., 2009) . It has been reported that most of the biophysical properties of hippocampal neurons in aged subjects remain constant over the life span (Burke and Barnes, 2006) . These include resting membrane potential, membrane time constant, input resistance, threshold to reach an action potential, and the width and amplitude of Na þ dependent action potential (for a review, see (Burke and Barnes, 2006) (Thibault and Landfield, 1996) that might lead to disruptions in Ca 2þ homeostasis (Toescu et al., 2004) , contributing to the plasticity deficits that occur with ageing. DA innervation in hippocampus, arisen mainly from the midbrain dopaminergic pathways, plays an important modulatory role for hippocampal function (Wittmann et al., 2005) . Long-term potentiation in the hippocampus can be enhanced and prolonged by dopaminergic inputs from midbrain structures (Morris et al., 2003) .
On the other hand, it has been reported since the late 80's that after L-Dopa loading, DA, DOPAC and HVA are increased in striatum, hypothalamus, hippocampus and cerebellum, with the largest increases in those tissues with less dopaminergic activity (el Gemayel et al., 1986) . This study suggested alternative sources of DA release in those regions. Recent studies have demonstrated that serotonergic innervations to hippocampus serve as an important source of DA release induced by L-DOPA treatment (Navailles et al., 2010 (Navailles et al., , 2013 . DA D1 and D5 receptors are involved in the persistence of LTP (Frey et al., 1991; Swanson-Park et al., 1999) . On the other hand, Otmakhova and Lisman showed that DA strongly inhibits the response to perforant pathway (pp) stimulation (IC50; 3 mM), but not the response to Schaffer collateral stimulation (Otmakhova and Lisman, 1999) . DA reduces both the NMDA and AMPA components of transmission at the pp (Otmakhova and Lisman, 1999) . The data from this study showed that there is a natural increase of the D5r, D3r and D2r densities in the normal ageing rat hippocampus. This observation is in concordance with other data in the literature showing that old subjects' dopaminergic systems undergo changes in DA receptor density in the hippocampus (Amenta et al., 2001; Hemby et al., 2003; Xing et al., 2010) . DA D3 receptor regulates cAMP-response element binding protein (CREB) signalling, which is one of the cellular molecules that has been strongly implicated in synaptic plasticity (Xing et al., 2010) . Alterations in the DA D3r signalling were reported in age-related memory and cognitive impairment (Xing et al., 2010) . Furthermore, a reduced concentration of DA in the dorsal hippocampus of aged rats (Stemmelin et al., 2000) could render them less able to compensate for the fluctuating concentrations of DA resulting from pulsatile L-Dopa treatment, as observed in this study.
We have extended the previous observations on the constitutive Fos expression in the rat hippocampus (Desjardins et al., 1997) by measuring two time points between two L-Dopa administrations. Interestingly, we have observed a spontaneously increased Fos induction during the late phase of the inter-administration period in the hippocampus. In fact, the observed cognitive impairment was temporally mirrored by a blunted MWM-induced activation of Fos expression in the hippocampus (Fos counts after MWM vs. Fos counts at Basal 12 h, Fig. 4, panel F, shade areas) . As we mentioned before, there was a significant global reduction of the ratio D5r/D3r comparing the old treated subjects with the young ones, which implicated a pronounced, up-regulated expression of the D3r in the old rat's hippocampus. D3r's function is of particular interest because evidence suggests its effects are primarily inhibitory (Flores et al., 1996) . 4.2. Differential effect of chronic L-Dopa treatment on mood and cognition in young and aged intact rats As early as 1971, Persson and Walinder reported nonParkinsonian human cases in which L-Dopa treatment caused short-term alleviating but longeterm exacerbating effects on depressive symptoms e just one month of treatment already prompted patients with worsening of original depressive symptoms (Persson and Walinder, 1971) . In the present study, we set out to test the effect of a pulsatile chronic administration scheme of LDopa on mood and cognition in an intact rat model, emphasizing a comparison at two different ages. We chose a common clinical used dose and application format. With RFST, an established and predictive animal model for the study of depression in which antidepressants typically reduce the duration of the immobility exhibited (Lucki et al., 2001; Porsolt et al., 1977b) , we observed that in the first day of the test all the experimental groups had similar performance, discarding any possible locomotor impairment by chronic LDopa treatment. In the second day of RFST, aged-treated rats showed increased immobility compared to controls. This finding is in accordance with a recent study that used longer and higher doses of L-Dopa in intact young rats, and showed increased immobility in a forced swimming test correlated with impaired DA and serotonin metabolism in some brain areas (Borah and Mohanakumar, 2007) .
The sucrose intake test assesses another aspect of depressionlike behaviour in rats. A reduction of the sucrose liquid intake provides an indirect measure of desensitization of the brain reward mechanisms. Aged treated subjects had a marked reduction of sucrose intake, indicating anhedonia which defined as a lowered ability to experience pleasure, an important component of depression. The putative neural substrate of anhedonia is represented by the dysfunction of a dopaminergic mesolimbic reward circuit involving the ventral striatum (nucleus accumbens), the prefrontal cortex and the entorhinal and amygdaloid complexes (Berke and Hyman, 2000; Kondo, 2008; Tanti and Belzung, 2010) . These structures, and particularly the dopaminergic receptors in the nucleus accumbens, are considered to mediate the euphorising effects of psychostimulants, antiparkinsonian drugs and gustatory reward (Cantello et al., 1989; Norgren et al., 2006) or, as elsewhere suggested, mediate behavioural activation and effort-related processes (Salamone et al., 2007) . Our observation suggests an alteration in DA responsiveness in the above regions.
The DAr expression patterns we observed in young control rats (Fig. 6 , panels As) are in concordance with those reported in literature on the subject (Ciliax et al., 2000) . The elevation of D3r in LDopa treated subjects has also been reported (Joyce et al., 2004) . Conversely, we have observed significant increases of D2r, D3r and D5r expression the cell body layer in CA1, CA2, CA3 and DG in aged rats (Fig. 6 , panel C, D, E, F respectively) which is in discrepancy with a study in humans using positron emission tomography (PET) in which a 10% of loss of D2r/D3r in the hippocampus was reported (Kaasinen et al., 2000) . One possible explanation of this discrepancy is that the resolution of a PET image study is much lower than immunohistochemistry combined with confocal microscopy as we used in our study. The altered hippocampal D5r /D3r and D5r/D2r ratios in the old treated group matched with lower sucrose consumption and increased immobility in RFST. Given that the hippocampus is involved in the feedback regulation of the HPA axis function, structural and functional changes in hippocampus are related to mood disorders, including depression, which could result from an inability to appropriately respond to stress (Duman et al., 1999) . DA receptors are also implicated in the underlying mechanisms in mood modulation; for example, antidepressants based on adenosine receptor antagonists probably involve interaction with D2 receptors (Crema et al., 2013) .
Technical consideration for the usage of cumulative probability of escape latency (CPFEL) for the Morris Water Maze test analysis
Regarding the MWM performance analysis, It is worth mentioning that the significant interaction between "age", "treatment" and "trial" factors made the differences observed difficult to interpret using ANOVA and the Bonferroni pos hoc test. This is a common problem for the experiments on spatial learning such as the MWM test: the individual differences and the not-fully predictable nature of rat behaviour increase the variation for a given trial, and the lack of independence between the different trials. The trial correlation is clearly observed in the experiment, and it is an expected result for a learning-type curve, at least for the control group. On the other hand, the variability of the response of the rat in a specific trial could be, even less probable, a temporal behaviour that does not necessarily reflect its intrinsic learning process. Evidently, this problem can be solved increasing the n, but by using the cumulative probability of escape latency (CPFEL), as proposed in this study, in addition to the repeated measure ANOVA analysis, this problem can be better solved with smaller n. Moreover, using this probabilistic approach can reveal additional characteristics of the rat behaviour. Firstly, the usual analysis could only report the mean latency time of escape with its variability at a definite trial and could not answer the question: at which time does the population learn the task? As an example, see Fig. 3C . We could interpret that the experimental old group learn to escape in the trial IV and on trial V the group unlearnt it. Therefore, did the group learnt to escape on trial IV or did they not? In our analysis it is possible to extract this information because we answer that half of the experimental old population was able to learn to escape on trial VI with a time lower than 22.5 s. This information provides useful aspects complementing those reported in the traditional analysis. Secondly, the usual way to report the variation is to report the standard error for each trial, because the variation of all of the trials does not have any sense. However, with our analysis we could report the variability of the behaviour of the population, and as can be seen, this variability increases with the age group, as the common sense would indicate, but now in a quantitative way of testing it. However, we have to be aware that the span of time chosen could affect the estimators or l and k.
Conclusion remark and implications for palliative care in Parkinson's diseae
Receptor up-and down-regulation has long been implicated in adaptive responses to continued pharmacological stimuli. Our results indicate that a chronic pulsatile L-Dopa treatment within the therapeutic range could produce depression-like behaviour and spatial learning impairment in intact rats, with aged subjects being more vulnerable. Dopaminergic receptor dysregulation is implicated as the underlying mechanism for the demonstrated emotional and cognitive dysfunctions.
In the past, the non-motor symptoms of PD patients have received little attention, particularly in the clinical settings (Bunting-Perry, 2006) . Patients with this disorder often develop depression and cognitive decline culminating in dementia (Cummings, 1992; Leverenz et al., 2009; Svenningsson et al., 2012) . The results of this study could have important implications for elderly patients who are treated with L-Dopa for Parkinsonism and who often develop cognitive impairment and emotional disturbances. Hence, this study calls attention to the need for heightened monitoring of emotional and cognitive functions, as well as accentuated palliative care for elderly Parkinson's patients treated with L-Dopa.
